Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintbilo in Chinese Heterozygous Familial Hypercholesterolemia
NCT04759534Phase 3Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- Sep 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heterozygous familial hypercholesterolemia (HeFH), sponsored by Shenzhen People's Hospital. Status: unknown.
02
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT04759534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04759534.